Unichem Laboratories has received Establishment Inspection Reports (EIR) from the US Food and Drug Administration (USFDA) indicating closure of inspections at both the API manufacturing facilities located at Pithampur and Roha.
The inspection at Pithampur was conducted by the USFDA from July 23, 2018 to July 27, 2018, while the inspection at Roha was conducted by the USFDA from July 30, 2018 to August 3, 2018.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
